The Biosimilar Growth Hormones market size is expected to reach $1.46 billion in 2030 at a CAGR of 10.5%, driven by rising cases of growth hormone deficiency in children.
Read More
The Biosimilar Contract Manufacturing market size is expected to reach $20.35 billion in 2030 at a CAGR of 15.4%, driven by growing prevalence of diabetes globally.
Read More
The Bioprocess Analyzers market size is expected to reach $3.35 billion in 2030 at a CAGR of 8.6%, driven by rising demand for biopharmaceutical production.
Read More
The Biopharmaceutical Lab Equipment market size is expected to reach $25.72 billion in 2030 at a CAGR of 7.6%, driven by increasing emphasis on personalized medicine.
Read More
The Biopharmaceutical Fermentation Systems market size is expected to reach $41.42 billion in 2030 at a CAGR of 9.4%, driven by expansion of the global biologics pipeline.
Read More
The Biopharmaceutical Excipients market size is expected to reach $5.04 billion in 2030 at a CAGR of 9.0%, driven by growing demand for vaccine development worldwide.
Read More
The Biomarkers market size is expected to reach $150.52 billion in 2030 at a CAGR of 14.2%, driven by increasing incidence of cardiovascular diseases.
Read More
The Biologics Manufacturing market size is expected to reach $106.08 billion in 2030 at a CAGR of 20.3%, driven by rising prevalence of chronic diseases.
Read More
The Biologics CDMO market size is expected to reach $48.07 billion in 2030 at a CAGR of 14.9%, driven by surging demand for cell and gene therapies.
Read More
The Biologics market size is expected to reach $827.24 billion in 2030 at a CAGR of 11.2%, driven by rising demand for personalized medicine.
Read More